Felipe Couñago, National Clinical Director of GenesisCare Spain, shared on X:
“Just published in Clinical Oncology!
Meta-analysis of 5 phase III trials (5,172 patients): no OS benefit with whole-pelvis RT.
Routine elective pelvic irradiation is not supported in unselected patients. Congrats to all co-authors!”
Title: Whole-pelvic versus prostate-only radiotherapy in clinically node-negative high-risk localised prostate cancer: a systematic review and meta-analysis with reconstructed individual-patient data
Authors: José Daniel Subiela, Elías Gomis Sellés, Fernando López Campos, Júlia Aumatell, Daniel Antonio González-Padilla, Álvaro Gonzalo Balbás, David López-Curtis, Victoria Vera Barragán, Jorge Caño-Velasco, Natalia Picola Brau, Pedro de Pablos-Rodríguez, Juan Gómez Rivas, Luis San-José Manso, Francisco Javier Burgos Revilla, Francesco Barletta, Filippo Alongi, Constantinos Zamboglou, Luca Nicosia, Mohamed Shelan, Antonio-José Conde-Moreno, Pablo Gajate, Patricia Guerrero, Òscar Buisan, and Felipe Couñago.
Andrew Loblaw, Professor and Clinician Scientist, Radiation Oncology at Sunnybrook Health Sciences Centre, shared Felipe Couñago’s post, adding:
“So important! Thanks to Felipe Couñago and team.”
Other articles about Prostate Cancer on OncoDaily.